betterlife pharma.png
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
September 27, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife and Collaborators to Submit Key Joint Research Publication
September 07, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects
August 24, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), is an emerging biotech company focused...
_0000_sentieo-logo-app-transp.png
Sentieo’s New Partnership with Fitch Solutions Amplifies Credit Research Content
July 21, 2022 08:30 ET | Sentieo
SAN FRANCISCO, July 21, 2022 (GLOBE NEWSWIRE) -- Sentieo, an AlphaSense company and maker of a leading AI-powered financial intelligence platform specifically designed for the research needs of...
betterlife pharma.png
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
June 23, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum
June 21, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
_0000_sentieo-logo-app-transp.png
Sentieo Adds Content From GLG, the World’s Insight Network
May 19, 2022 08:30 ET | Sentieo
SAN FRANCISCO, May 19, 2022 (GLOBE NEWSWIRE) -- Sentieo, maker of a leading AI-powered financial intelligence platform specifically designed for the research needs of investors, today announced a...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
April 21, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife New Logo.png
BetterLife Launches New Corporate Website
February 10, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on the...
Michael Noonan, COO, Sentieo
FinTech Leader Michael Noonan Joins Sentieo as Chief Operating Officer
November 01, 2021 08:00 ET | Sentieo
SAN FRANCISCO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Sentieo, the leading next-generation financial research platform provider, announced the appointment of Michael Noonan to Chief Operating Officer....